Janssen wins patent case against Sandoz over macitentan drug
Pharmaceutical manufacturer Janssen Inc. will continue to be the only company in Canada to provide a specific medicine used in the treatment of pulmonary arterial hypertension, after winning a patent case...To view the full article, register now.
Already a subscriber? Click here to view full article